articles
- Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer. 11:500-515. 2019
- Antibody-drug conjugate library prepared by scanning insertion of the aldehyde tag into IgG1 constant regions. 10:1182-1189. 2018
- Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain. 9:438-454. 2017
- Insertion of scFv into the hinge domain of full-length IgG1 monoclonal antibody results in tetravalent bispecific molecule with robust properties. 9:240-256. 2017
- A hingeless Fc fusion system for site-specific cleavage by IdeS. 8:1118-1125. 2016
- Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA. 8:1425-1434. 2016
- Antibody engineering & therapeutics, the annual meeting of the antibody society December 7-10, 2015, San Diego, CA, USA. 8:617-652. 2016
- Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity. 8:1498-1511. 2016
- Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies. 8:501-512. 2016
- Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. 8:1347-1360. 2016
- Molecular basis for the mechanism of action of an anti-TACE antibody. 8:1598-1605. 2016
- The INNs and outs of antibody nonproprietary names. 8:1-9. 2016
- The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies. 7:1084-1093. 2015
- Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA. 7:981-988. 2015
- Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA. 6:577-618. 2014
- Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins. 6:671-678. 2014
- Antibody engineering and therapeutics conference The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014. 6:1115-1123. 2014
- The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics. 5:851-859. 2013
- Monoclonal antibody therapeutics with up to five specificities: Functional enhancement through fusion of target-specific peptides. 5:208-218. 2013
- The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen. 5:364-372. 2013
- Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis. 4:600-613. 2012
- Targeting malignant B cells with an immunotoxin against ROR1. 4:349-361. 2012
- Characterization of the basic charge variants of a human IgG1: effect of copper concentration in cell culture media. 3:577-583. 2011
- Comparability analysis of protein therapeutics by bottom-up LC-MS with stable isotope-tagged reference standards. 3:387-395. 2011
- Mining human antibody repertoires. 2:365-378. 2010